Related Experiment Video

Updated: Aug 1, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and

M F Lampe1, K G Wong, L M Kuehl

  • 1Department of Medicine, University of Washington, Seattle 98195, USA. lampe@u.washington.edu

Infection and Immunity
|January 1, 1997
PubMed

Insights

Novel Chlamydia trachomatis variants with altered major outer membrane protein (MOMP) can evade antibody neutralization. This finding is crucial for understanding immune escape mechanisms and developing effective trachoma treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Chlamydia trachomatis is a leading cause of preventable blindness worldwide.
  • The major outer membrane protein (MOMP) is a key target for neutralizing antibodies.
  • Emergence of MOMP variants may impact vaccine efficacy and treatment strategies.

Purpose of the Study:

  • To investigate whether novel Chlamydia trachomatis isolates with specific MOMP amino acid changes can escape antibody-mediated neutralization of infectivity.
  • To assess the functional significance of MOMP variants in evading immune responses.

Main Methods:

  • Identification of novel Chlamydia trachomatis isolates with MOMP variable domain mutations.
  • Utilized a complement-independent in vitro neutralization assay.
  • Tested prototype strains (D and I) and their variants against monoclonal antibodies and polyclonal human immune sera.

Main Results:

  • Identified two families of MOMP variants: D-related (Da, D*, D-) and I-related (Ia, I-).
  • Demonstrated that these MOMP variants can escape neutralization by antibodies that neutralize prototype strains.
  • Observed antibody evasion against both specific monoclonal antibodies and broader polyclonal human immune sera.

Conclusions:

  • Novel Chlamydia trachomatis MOMP variants exhibit immune evasion capabilities.
  • These variants can escape neutralization by antibodies targeting prototype strains.
  • Findings highlight the potential for immune escape and necessitate consideration in future Chlamydia trachomatis control strategies and vaccine development.

More Related Videos

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis10:35

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Published on: January 30, 2020

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Related Concept Videos

Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.